Patient-Derived Organoids for Rectal Cancer

See also
Status	Clinical Trial	Phase
Recruiting	`NCT05400122` - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer	Phase 1
Completed	`NCT00409994` - Safety Study of Rapamycin Administered Before and During Radiotherapy to Treat Rectum Cancer	Phase 1/Phase 2
Recruiting	`NCT04916990` - Improving Care for Rural Patients With Solid Tumors	N/A
Active, not recruiting	`NCT05305820` - Perioperative Exercise and Nutritional Optimisation Prehabilitation Before Surgery for Patients With Peritoneal Malignancy	N/A
Recruiting	`NCT03699761` - The Role of Pelvic Peritonization in Laparoscopic or Robotic Low Anterior Resection	N/A
Recruiting	`NCT04907643` - Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes	N/A
Completed	`NCT03843957` - Effectiveness and Implementation of mPATH-CRC	N/A
Completed	`NCT02423226` - Computed Tomography-guided Brachytherapy Plus Chemotherapy for Locally Recurrent Rectum Cancer	Phase 2
Completed	`NCT00379743` - Partnership for Healthy Seniors	N/A
Completed	`NCT00509444` - Cancer Prevention and Treatment Among African American Older Adults: Treatment Trial	Phase 3
Recruiting	`NCT06116019` - Online Adaptive Radiotherapy Using a Novel Linear Accelerator (ETHOS)
Not yet recruiting	`NCT06066931` - Reconstruction of the Pelvic Floor and Perineal Wound After Rectal ELAPE	N/A
Recruiting	`NCT02738359` - Efficacy of Colonoscopy, Colon Capsule and Fecal Immunological Test for Colorectal Cancer Screening
Completed	`NCT02997553` - Fluorescence for Sentinel Lymph Node Identification in Cancer Surgery	Phase 3
Active, not recruiting	`NCT02458664` - BASE HSP110 : A New Therapeutic Target and a New Marker for Prognosis of Type MSI Colorectal Cancer	N/A
Withdrawn	`NCT03257332` - Determining Early Development of Faecal Incontinence and Anorectal Muscle Function After Surgery for Rectal Cancer.
Recruiting	`NCT05715255` - Adaptive Symptom Self-Management Immunotherapy Study	N/A
Completed	`NCT02641691` - Non-Operative Radiation Management of Adenocarcinoma of the Lower Rectum	Phase 2
Recruiting	`NCT04405206` - Total Neoadjuvant Therapy Followed by 'Watch and Wait' Approach or Organ Preservation for Low-risk Rectal Cancer
Recruiting	`NCT03573791` - Biomarkers for Predicting Neoadjuvant Chemoradio-resistance for Middle-low Advanced Rectal Cancer

NCT number	NCT04371198
Study type	Interventional
Source	Duke University
Contact
Status	Completed
Phase	N/A
Start date	September 18, 2020
Completion date	August 17, 2022

Patient-Derived Organoids for Rectal Cancer

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms